Vaccines (Jul 2023)

Serological Evaluation for Measles among Italian and Foreign Medical Students in a University Hospital in Rome

  • Luca Coppeta,
  • Cristiana Ferrari,
  • Giuseppina Somma,
  • Viola Giovinazzo,
  • Ersilia Buonomo,
  • Marco Trabucco Aurilio,
  • Michele Treglia,
  • Andrea Magrini

DOI
https://doi.org/10.3390/vaccines11071256
Journal volume & issue
Vol. 11, no. 7
p. 1256

Abstract

Read online

Background: Measles infection in the hospital setting is a major issue. Despite the availability of an effective vaccine, measles outbreaks continue to occur in some European countries. We aimed to evaluate the immunological status of medical students attending the Tor Vergata Polyclinic (PTV). Methods: Measles antibodies titers were assessed by venipuncture on a sample of 2717 medical students who underwent annual health surveillance visits from January 2021 to March 2023. Subjects showing serum IgG values above 1.0 S/CO were considered serologically protected. Personal data, country of origin, and main demographic characteristic were also collected. Results: 66.7% (1467 Italian and 346 foreign) of medical students showed protective IgG antibodies levels. Female students were serologically immune more frequently than males (68.6% vs. 63.3%; p p p < 0.01). Albanian students, who were the largest foreign population in our study, showed a low serological protection rate (40/90: 44.4%). Conclusions: The proportion of serologically non-immune students is high, raising concerns about the possible risk of hospital transmission. Substantial differences in the rate of immunity have been found between subjects coming from different parts of Europe and the world. Pre-training assessment of all medical students and vaccination of susceptible individuals is highly recommended, particularly for those from low immunization rate countries.

Keywords